L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages (Q38730205)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 November 2016

Language	Label	Description	Also known as
English	L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages	scientific article published on 18 November 2016

Statements

scholarly article

1 reference

Europe PubMed Central

5 September 2017

L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages (English)

1 reference

Europe PubMed Central

5 September 2017

inflammasome complex

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Tzu-Ching Yang

1

1 reference

Europe PubMed Central

5 September 2017

Po-Yuan Chang

2

1 reference

Europe PubMed Central

5 September 2017

Shao-Chun Lu

3

1 reference

Europe PubMed Central

5 September 2017

publication date

18 November 2016

1 reference

Europe PubMed Central

5 September 2017

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

5 September 2017

312

1 reference

Europe PubMed Central

5 September 2017

2

1 reference

Europe PubMed Central

5 September 2017

H265-H274

1 reference

Europe PubMed Central

5 September 2017

Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Molecular cloning of the interleukin-1 beta converting enzyme

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

LPS-Induced G-CSF Expression in Macrophages Is Mediated by ERK2, but Not ERK1

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Rapamycin inhibits lipopolysaccharide induction of granulocyte-colony stimulating factor and inducible nitric oxide synthase expression in macrophages by reducing the levels of octamer-binding factor-2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Electronegative LDL induces priming and inflammasome activation leading to IL-1β release in human monocytes and macrophages.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Electronegative LDL: a circulating modified LDL with a role in inflammation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Review: Transcriptional and post-transcriptional regulation of interleukin 1 gene expression

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Low-density lipoprotein electronegativity is a novel cardiometabolic risk factor

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Oxidized LDL: diversity, patterns of recognition, and pathophysiology

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Electronegative LDL impairs vascular endothelial cell integrity in diabetes by disrupting fibroblast growth factor 2 (FGF2) autoregulation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Development of a sensitive multi-well colorimetric assay for active NFkappaB

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Role of LOX-1 in monocyte adhesion-triggered redox, Akt/eNOS and Ca2+ signaling pathways in endothelial cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Electronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

The NLRP3 inflammasome: a sensor for metabolic danger?

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Inflammatory markers in ST-elevation acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Cholesterol, inflammation and innate immunity

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Targeting interleukin-1 in heart disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Danger signaling in atherosclerosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00509.2016

21 January 2018

Identifiers

10.1152/AJPHEART.00509.2016

1 reference

Europe PubMed Central

5 September 2017

release_lpd4fec66zejvl5mossqu7djj4

1 reference

https://api.fatcat.wiki/v0/release/lpd4fec66zejvl5mossqu7djj4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

5 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38730205&oldid=1836910484"